Search

everythinglearnresearchcommunity

for

Search:↓

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Cyclosporin doesn't stop hair loss.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Interest in new and personalized treatments for hair loss is growing.

Current treatments for androgenetic alopecia are complex and promising, but more research is needed.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

The document concludes that early recognition and appropriate treatment of red scalp, red ear, and red scrotum syndromes can lead to remission.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Estrogen therapy can reduce skin aging but has cancer risks.

Spironolactone plus finasteride reduces hirsutism more effectively.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Minoxidil modestly increases hair growth in men with early baldness and is safe to use.

Thicker hair grows faster; hair loss patients have slower growth.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.